Pipeline Invest Information

BioNTech Projects Ten Oncology Trials by End of 2024 Leading to First Launch in 2026 Mar 20, 2024

Intellia Therapeutics Surpasses Q3 Earnings Expectations and Announces Progress in Gene-Editing Pipeline Nov 11, 2023

Immunovant Surpasses Q2 Earnings Expectations with a Strong Focus on Future Pipeline Nov 10, 2023